云南高校图书馆联盟文献共享服务平台- HEPATOCELLULAR

HEPATOCELLULAR: 作品数：1273被引量：7979H指数：37; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：张福君张亮吴沛宏顾仰葵赵明更多>>; 相关机构：第二军医大学中山大学中国人民解放军总医院广州军区广州总医院更多>>; 相关期刊：更多>>; 相关基金：国家自然科学基金国家重点基础研究发展计划中国博士后科学基金广东省自然科学基金更多>>

Surgical treatment strategies for multifocal hepatocellular carcinomas: 《Hepatobiliary Surgery and Nutrition》2024年第6期1071-1076,共6页Xuehai Jia Anque Liao Li Jiang; supported by the National Natural Science Foundation of China(No.82470652 to L.J.);Sichuan Province Key Research and Development Project(No.2019YFS0203 to L.J.);Key Clinical Research Incubation Project of West China Hospital of Sichuan University(No.2020HXFH028 to L.J.);Key R&D Support Plan of Chengdu Science and Technology Bureau(No.2021-YF05-00703-SN to L.J.);Sichuan Province Key Research and Development Project(No.2022YFS0090 to L.J.);Sichuan Natural Science Foundation project(No.24NSFSC0237 to L.J.).; The multifocality of hepatocellular carcinoma(HCC)still represents considerable challenges,with generally poorer outcomes compared to the single HCC(SH).According to the Barcelona Clinic Liver Cancer(BCLC)guideline,on...; 关键词：MULTIFOCAL HEPATOCELLULAR LIVER

Laparoscopic anatomical versus non-anatomical liver resection for hepatocellular carcinoma in the posterosuperior segments:a propensity score matched analysis被引量：4: 《Hepatobiliary Surgery and Nutrition》2023年第6期824-834,I0001,共12页Boram Lee Jai Young Cho Ho-Seong Han Yoo-Seok Yoon Hae Won Lee Jun Suh Lee Moonhwan Kim Yeongsoo Jo; support (Grant No.02-2021-046)from Seoul National University Bundang Hospital Research Fund.; Background:Since laparoscopic anatomical resection(LAR)for tumors,especially located in the posterosuperior(PS)segments of the liver remains difficult,laparoscopic non-anatomical resection(LNAR)are generally preferred...; 关键词：LAPAROSCOPY HEPATECTOMY carcinoma hepatocellular RECURRENCE

Novel preoperative strategies to improve hepatocellular carcinoma resectability: 《Hepatobiliary Surgery and Nutrition》2023年第1期140-141,共2页Francisco Tustumi Fabricio Ferreira Coelho Paulo Herman; Peng et al.(1)performed a pretty interesting article,reporting the proposal of a new strategy to improve resectability for hepatocellular carcinoma(HCC).Their findings are exciting.Preoperative strategies to improve l...; 关键词：HEPATOCELLULAR LIVER

The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma: 《Hepatobiliary Surgery and Nutrition》2023年第1期142-143,共2页Tao He Jieyu Zou Ke Sun; It was with great interest that we read the document by Yang et al.entitled“Impact of pathological response after preoperative transcatheter arterial chemoembolization(TACE)on incidences of microvascular invasion and...; 关键词：INVASION SURGERY HEPATOCELLULAR

The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumab: 《Hepatobiliary Surgery and Nutrition》2023年第1期148-150,共3页Sabine Lieb Sebastian Ebel Daniel Seehofer Thomas Berg Florian van Bommel; With great interest we have read the comment of Dr.Khakoo on the recently published CRAFITY score for the prediction of response to anti-programmed death(ligand)1[PD-(L)1]-based immunotherapy in patients with unresect...; 关键词：PATIENTS HEPATOCELLULAR carcinoma

Evolution of systemic therapy for advanced-stage hepatocellular carcinoma: 《Hepatobiliary Surgery and Nutrition》2022年第6期899-902,共4页Moon Haeng Hur Yoon Jun Kim; Since the introduction of sorafenib in 2007(1),a tyrosine kinase inhibitor(TKI),there have been notable advancements in systemic therapy for advanced-stage hepatocellular carcinoma(HCC).Although the European Associati...; 关键词：HEPATOCELLULAR LIVER Clinical

Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option: 《Hepatobiliary Surgery and Nutrition》2022年第6期870-872,共3页Julie Leclerc Ahmet Ayav; In this multicentric retrospective study(1),the authors aimed to compare surgery versus Sorafenib(SOR)for the treatment of advanced nonmetastatic hepatocellular carcinoma(HCC).Data were collected from two Italian regi...; 关键词：surgery HEPATOCELLULAR METASTATIC

Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma: 《Hepatobiliary Surgery and Nutrition》2022年第6期876-878,共3页Shinji Itoh Masafumi Ikeda; Atezolizumab plus bevacizumab is currently the main choice of first-line treatment for unresectable hepatocellular carcinoma(HCC),which has been proven superior to sorafenib for overall survival(OS)and progression-fre...; 关键词：BEVACIZUMAB HEPATOCELLULAR PATIENTS

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma: 《Hepatobiliary Surgery and Nutrition》2022年第5期735-737,共3页Margaret L.P.Teng Kai En Chan Darren J.H.Tan Daniel Q.Huang; Non-alcoholic fatty liver disease(NAFLD)is the fastest growing cause of hepatocellular carcinoma(HCC)worldwide(1).It is anticipated that the burden of NAFLD-related HCC will continue to increase in tandem with the glo...; 关键词：HEPATOCELLULAR NAFLD LIVER

New developments in ablation therapy for hepatocellular carcinoma:combination with systemic therapy and radiotherapy: 《Hepatobiliary Surgery and Nutrition》2022年第5期766-769,共4页Kauzshi Numata Feiqian Wang; supported by the National Natural Science Foundation of China(No.82102074)Key Science and Technology Program of Shaanxi Province of China(No.2022SF-320).; We carefully read the review article,which compared three types of ablation therapies such as radiofrequency ablation(RFA),high-intensity focused ultrasound(HIFU),and microwave ablation(MWA)for Barcelona clinic liver ...; 关键词：SURGERY HEPATOCELLULAR al.

HEPATOCELLULAR